Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Gut Microbiome and Metastatic Renal Cell Carcinoma
Luís Meza, Matthew Feng, Kyle O. Lee, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1502-1502
Open Access | Times Cited: 11

Showing 11 citing articles:

Emerging role of exosomes in cancer therapy: progress and challenges
Jiale Li, Jiachong Wang, Zigui Chen
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
The Gut–Organ Axis within the Human Body: Gut Dysbiosis and the Role of Prebiotics
Georgia Saxami, Evangelia N. Kerezoudi, Christos Eliopoulos, et al.
Life (2023) Vol. 13, Iss. 10, pp. 2023-2023
Open Access | Times Cited: 25
Update on Biomarkers in Renal Cell Carcinoma
Renée Maria Saliby, Eddy Saad, Soki Kashima, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 2
Closed Access | Times Cited: 10
Understanding and overcoming resistance to immunotherapy in genitourinary cancers
S. Evans, Yash Jani, Caroline S. Jansen, et al.
Cancer Biology & Therapy (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 7
Unveiling the intratumoral microbiota within cancer landscapes
Shusheng Che, Zhiyong Yan, Yugong Feng, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109893-109893
Open Access | Times Cited: 6
Genetically predicted inflammatory proteins mediate the association between gut microbiota and renal cell carcinoma
Xinyun Zou, Dong Li, Ling Zhang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma
Albert Jang, Jake Lichterman, Jeffrey Y. Zhong, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 5
Exploring the gut microbiome and immunological landscape in kidney cancer: a Mendelian randomization analysis
Shihui Lv, Qian Guo, Yuhan He, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Exosome in renal cell carcinoma progression and implications for targeted therapy
Xinwei Li, Wenjun Xiao, Hongmei Yang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
New players in the landscape of renal cell carcinoma bone metastasis and therapeutic opportunities
Beatrice Cesana, Claude Cochet, Odile Filhol
International Journal of Cancer (2024)
Open Access
Validation of urine p-cresol glucuronide as renal cell carcinoma non-invasive biomarker
Júlia Oto, Raquel Herranz, P Verger, et al.
Journal of Proteomics (2024) Vol. 311, pp. 105357-105357
Closed Access
Page 1

Scroll to top